Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Mental Retardation | 2 |
| Seizures | 2 |
| Surgery | 2 |
| Attention Deficit… | 1 |
| Autism | 1 |
| Cerebral Palsy | 1 |
| Clinical Diagnosis | 1 |
| Developmental Disabilities | 1 |
| Dietetics | 1 |
| Drug Therapy | 1 |
| Epilepsy | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Descriptive | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkDepositario-Cabacar, Dewi Frances T.; Zelleke, Tesfaye-Getaneh – Developmental Disabilities Research Reviews, 2010
Children with developmental disabilities are at increased risk for epilepsy with a prevalence rate higher than the general population. Some of the more common developmental disorders in childhood and the features of epilepsy in these conditions are discussed. Specifically, autism, cerebral palsy, mental retardation, and attention deficit and…
Descriptors: Epilepsy, Mental Retardation, Quality of Life, Developmental Disabilities
Gladston, S.; Clarke, D. J. – Journal of Intellectual Disability Research, 2005
Clozapine is licensed for the treatment of psychotic illnesses resistant to other antipsychotic medications. Velo-cardio-facial syndrome (VCFS) is associated with a vulnerability to psychotic illness that may be resistant to treatment with conventional typical and atypical antipsychotics. A 32-year-old man with intellectual disability (ID) and a…
Descriptors: Surgery, Patients, Seizures, Psychosis
